DAVID RIMMER

BAY ST LOUIS, MS NPI 1619976636

General Payments — all program years on this page

$2,126.81

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 96
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $374.62 across 16 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $374.6216

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $220.6614
2019 $453.5519
2020 $126.175
2021 $507.2722
2022 $170.407
2023 $274.1413
2024 $374.6216

Records — PY2024 (16)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1100677237 Cardinal Health 414 LLC $29.03 05/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105917600 VERTEX PHARMACEUTICALS INCORPORATED $19.70 10/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105950537 ABBVIE INC. $24.74 06/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116874891 Medtronic, Inc. $26.30 11/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137662552 Takeda Pharmaceuticals U.S.A., Inc. $19.39 01/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137662554 Takeda Pharmaceuticals U.S.A., Inc. $16.85 03/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137662556 Takeda Pharmaceuticals U.S.A., Inc. $15.51 04/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137662558 Takeda Pharmaceuticals U.S.A., Inc. $14.36 05/02/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137662560 Takeda Pharmaceuticals U.S.A., Inc. $17.02 07/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137662562 Takeda Pharmaceuticals U.S.A., Inc. $24.24 10/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1137662564 Takeda Pharmaceuticals U.S.A., Inc. $18.57 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142400816 CONMED Corporation $71.43 08/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154190140 TELA Bio, Inc. $19.38 01/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154190142 TELA Bio, Inc. $18.70 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154190144 TELA Bio, Inc. $19.70 02/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1154190146 TELA Bio, Inc. $19.70 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.